Developmental Outcomes of Extreme Prematurity, 5-15 Years Postpartum

Sponsor
Sheba Medical Center (Other)
Overall Status
Terminated
CT.gov ID
NCT01430832
Collaborator
(none)
95
1
2
47.4

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the emotional well being of mothers to preterm infants with ELBW 5-15 years after the birth. Post-traumatic symptoms and parental stress levels will be taken into consideration. In addition, the correlation between the infant's development and the mother's emotional state will be analyzed.

Detailed Description

Medical records of the children will be used for information in four categories: prenatal, birth, development,and demographic information. Parents will be contacted and interviewed regarding the child's development. In addition, they will complete the following questionnaires: PPQ-II Perinatal PTSD Questionnaire- modified, PTGI -The Posttraumatic Growth Inventory,Parental Stress Index- Short Form- PSI-SF, and Life Events questionnaire.

Study Design

Study Type:
Observational
Actual Enrollment :
95 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Long-Term Developmental Outcomes of Extreme Prematurity: Correlations With Maternal Post-Traumatic Symptoms, Parental Stress and Post-Traumatic Growth, 5-15 Years Postpartum
Study Start Date :
Sep 1, 2011
Actual Primary Completion Date :
Nov 1, 2011
Actual Study Completion Date :
Nov 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Normal Development

The infant's development level will be assessed using a phone interview with parents

Abnormal Development

The infant's level of development will be assessed using a phone interview with parents

Outcome Measures

Primary Outcome Measures

  1. Not relevant [Not relevant]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Preterm Infant

  • Very low birth weight or extremely low birth weight

Exclusion Criteria:
  • Missing information regarding birth week and weight

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sheba Medical Center Ramat Gan Israel

Sponsors and Collaborators

  • Sheba Medical Center

Investigators

  • Principal Investigator: Lidia Gabis, MD, Sheba Medical Center
  • Principal Investigator: Gabi Zerach, Ph.D, Ariel University
  • Study Director: Shefer Shahar, Ph.D, Sheba Medical Center
  • Study Director: Adi Elsing, BA, Sheba Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT01430832
Other Study ID Numbers:
  • SHEBA-10-8121-LG-CTIL
First Posted:
Sep 8, 2011
Last Update Posted:
Jul 2, 2018
Last Verified:
Jun 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Sheba Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 2, 2018